Teva Pharmaceuticals Price Target Announced at $50.00/Share by Oppenheimer
Ratings actions from Benzinga: GMT) Teva Pharmaceuticals Initiated at Outperform by OppenheimerRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Teva Pharmaceuticals Initiated at Outperform by OppenheimerRatings actions from Benzinga